Mechanisms of Resistance and New Therapies in Ovarian Cancer

Our laboratory is dedicated to understanding the molecular mechanisms that drive tumorigenicity and therapeutic resistance in ovarian cancer—one of the most lethal gynecological malignancies worldwide. We focus on identifying the biological factors that contribute to poor patient outcomes and on developing innovative, personalized, and less invasive therapeutic strategies.